title: Generation of Helper Plasmids Encoding Mutant Adeno-associated Virus Type 2 Capsid Proteins with Increased Resistance against Proteasomal Degradation.
abstract: OBJECTIVE
  Adeno-associated virus type 2 (AAV2) vectors are widely used for both experimental and clinical gene therapy. A recent research has shown that the performance of these vectors can be greatly improved by substitution of specific surface-exposed tyrosine residues with phenylalanines. In this study, a fast and simple method is presented to generate AAV2 vector helper plasmids encoding capsid proteins with single, double or triple Y→F mutations.
  
  
  METHODS
  A one-step, high-fidelity polymerase chain reaction (PCR) cloning procedure involving the use of two partially overlapping primers to amplify a circular DNA template was applied to produce AAV2 cap genes encoding VP1 mutants with Y→F substitutions in residues 444, 500 or 730. The resulting constructs were used to make the different double and triple mutant by another round of PCR (Y444500F mutant), subcloning (Y444730F and Y500730F mutants) or a combination of both techniques (Y444500730F mutant).
  
  
  RESULTS
  Nucleotide sequence analysis revealed successful introduction of the desired mutations in the AAV2 cap gene and showed the absence of any unintended mutations in the DNA fragments used to assemble the final set of AAV2 vector helper plasmids. The correctness of these plasmids was further confirmed by restriction mapping.
  
  
  CONCLUSIONS
  PCR-based, single-step site-directed mutagenesis of circular DNA templates is a highly efficient and cost-effective method to generate AAV2 vector helper plasmids encoding mutant Cap proteins for the production of vector particles with increased gene transfer efficiency.
authors.affiliation: Shahroud University of Medical Sciences, Shahroud, Iran.
authors.forename: Naghmeh
authors.initials: N
authors.lastname: Ahmadiankia
authors.forename: Vajiheh
authors.initials: V
authors.lastname: Neshati
authors.forename: Zeinab
authors.initials: Z
authors.lastname: Neshati
authors.forename: Jim
authors.initials: J
authors.lastname: Swildens
authors.forename: Antoine Af
authors.initials: AA
authors.lastname: de Vries
keywords: Adeno-associated virus type 2; Capsid protein; Gene therapy; Mutagenesis; Proteasomal degradation; Transduction efficiency; Viral vector